Skip to content
10-K

Annual Report

BioCrude Technologies USA, Inc.

0001731122-22-000498

← back to feed
Filed
Mar 23, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Dec 31, 2021 50.71M sh
Cash And Equivalents FY 2022 · Dec 31, 2021 $1.78K
Cash And Equivalents FY 2022 · Dec 31, 2020 $109.97K
Cash And Equivalents FY 2022 · Dec 31, 2019 $305
Net Income FY 2022 · Dec 31, 2021 −$431.46K
Net Income FY 2022 · Dec 31, 2020 −$288.49K
Operating Cash Flow FY 2022 · Dec 31, 2020 −$279.58K
Total Liabilities FY 2022 · Dec 31, 2020 $278.3K
Total Assets FY 2022 · Dec 31, 2020 $129.67K
Sga Expense FY 2022 · Dec 31, 2020 $283.74K
Operating Income FY 2022 · Dec 31, 2020 −$283.74K